Bulletin
Investor Alert

Sesen Bio Inc.

NAS: SESN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Sesen Bio Inc.

After Hours

 --Quotes are delayed by 20 min

May 27, 2022, 7:20 p.m.

SESN
/zigman2/quotes/201402704/composite

$

0.53

Change

+0.0058 +1.10%

Volume

Volume 30,590

Quotes are delayed by 20 min

/zigman2/quotes/201402704/composite

Previous close

$ 0.52

$ 0.53

Change

+0.0029 +0.56%

Day low

Day high

$0.49

$0.53

Open

52 week low

52 week high

$0.37

$6.04

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Sesen Bio Inc.

View Ratios
Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 425,000--11.24M26.54M
Cost of Goods Sold (COGS) incl. D&A -208,000219,000-85,000
COGS excluding D&A -----
Depreciation & Amortization Expense 285,000208,000219,000122,00085,000
Depreciation 285,000208,000219,000122,00085,000
Amortization of Intangibles -----
Gross Income -(208,000)(219,000)-26.46M
20172018201920202021 5-year trend
SG&A Expense 20.13M25.49M36.65M43.37M54.62M
Research & Development 12.23M13.87M24.44M29.07M25.23M
Other SG&A 7.9M11.62M12.21M14.3M-
Other Operating Expense -----
Unusual Expense 9.27M8.8M71.62M(11.18M)(19.61M)
EBIT after Unusual Expense (29.25M)(34.5M)(108.49M)(21.08M)(8.55M)
Non Operating Income/Expense 221,000807,000991,000125,000(60,000)
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (29.03M)(33.69M)(107.5M)(20.95M)(8.61M)
Income Tax ---1.45M(8.27M)
Income Tax - Current Domestic -----
Income Tax - Current Foreign ---1.45M286,000
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign ----(8.56M)
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (29.03M)(33.69M)(107.5M)(22.4M)(336,000)
Minority Interest Expense -----
Net Income (29.03M)(33.69M)(107.5M)(22.4M)(336,000)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (29.03M)(33.69M)(107.5M)(22.4M)(336,000)
Preferred Dividends ---147,000-
Net Income Available to Common (29.03M)(33.69M)(107.5M)(22.54M)(336,000)
EPS (Basic) (1.11)(0.55)(1.18)(0.19)()
Basic Shares Outstanding 26.11M61.77M90.93M118.22M182.32M
EPS (Diluted) (1.11)(0.55)(1.18)(0.19)()
Diluted Shares Outstanding 26.11M61.77M90.93M118.22M182.32M
EBITDA (19.7M)(25.49M)(36.65M)(32.14M)(28.08M)
Copyright 2022 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Link to MarketWatch's Slice.